Warfarin Enantiomers Pharmacokinetics by CYP2C19

QR Code

Warfarin Enantiomers Pharmacokinetics by CYP2C19

None

Saved in:

Bibliographic Details
Main Authors:	Akamine, Yumiko, Uno, Tsukasa
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/32128
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CYP2C9*2 and CYP2C9*3 allele variants of CYP2C9 cytochrome gene in St. Petersburg population, and their clinical role in warfarin anticoagulant therapy
by: O. V. Sirotkina, et al.
Published: (2004-12-01)

Clinical Implications of Genetic Admixture in Hispanic Puerto Ricans: Impact on the Pharmacogenetics of CYP2C19 and PON1
by: Duconge, Jorge, et al.
Published: (2012)

Recrystallization of Enantiomers from Conglomerates
by: Dupray, Valérie
Published: (2012)

Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis.
by: Andrea L Jorgensen, et al.
Published: (2012-01-01)

Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
by: O. G. Gribakina, et al.
Published: (2020-04-01)

Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population
by: Elizabeth J. Thompson, et al.
Published: (2024-08-01)

A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin.
by: Songie Choi, et al.
Published: (2017-01-01)

CLINICAL SIGNIFICANCE OF STUDYING GENETIC POLYMORPHISM OF THE Р450 CYP2C9 AND CYP2C19 DETOXIFYING ENZYME GENES IN EPILEPTIC CHILDREN
by: O. V. Guzeva, et al.
Published: (2016-05-01)

Simultaneous LC-MS/MS Determination of Racemic Warfarin and Etravirine in Rat Plasma and Its Application in Pharmacokinetic Studies
by: John, Jyothy, et al.
Published: (2012)

Impact of <i>CYP2C9, CYP2C19</i> and <i>ABCB1</i> genetic polymorphisms on antiepileptic drug safety and efficacy
by: N. A. Galankin, et al.
Published: (2025-05-01)

Comparative Veterinary Pharmacokinetics
by: Jerzsele, Akos
Published: (2012)

Modeling the Influence of <i>CYP2C9</i> and <i>ABCB1</i> Gene Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Losartan
by: Dmitry Babaev, et al.
Published: (2025-07-01)

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

Pharmacokinetics of Antimicrobials in Food Producing Animals
by: Bhavsar, S. K., et al.
Published: (2012)

Study of the effect of anxiolytic GML-1 on the activity of cytochrome CYP2C9 and CYP1A2 isoforms
by: O. G. Gribakina, et al.
Published: (2019-02-01)

Pharmacokinetic – Pharmacodynamic Considerations for Bovine Mastitis Treatment
by: Mestorino, Nora, et al.
Published: (2012)

Pharmacokinetic Interactions of Antihypertensive Drugs with Citrus Juices
by: Uesawa, Yoshihiro
Published: (2012)

Clinically significant CYP2C19 genotypes in patients with myocardial infarction in the northern region of Russia
by: A. S. Vorobyov, et al.
Published: (2023-11-01)

PREVALENCE OF POLYMORPHOUS LOCUS 681G>A OF CYP2C19 GENE IN RUSSIAN POPULATION
by: T. A. Bairova, et al.
Published: (2014-11-01)

Polymorphisms of CYP1A1, CYP1A2, CYP19, and SULT1A1 genes in women with early miscarriage
by: I. N. Noskova, et al.
Published: (2019-12-01)

CYTOCHROME P450 (CYP2C9) ACTIVENESS, EVALUATED VIA LOSARTAN TEST, AS PREDICTION MARKER FOR THE WARFARIN TREATMENT DOSAGE CHOICE IN PATIENTS WITH DELAYED OUTCOMES AFTER HEART VALVES REPLACEMENT
by: S. M. Arslanbekova, et al.
Published: (2015-10-01)

The prevalence of allelic variants of VKORC1, CYP2C9 and CYP4F2 genes in Zaporizhzhia region population
by: M. Yu. Kolesnik, et al.
Published: (2019-03-01)

One Step Closer to the Target: Intracellular Pharmacokinetics of Gemcitabine
by: Links, Matthew, et al.
Published: (2012)

Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients After Renal Transplantation
by: Rath, Thomas, et al.
Published: (2012)

Inclusion interaction of cyclodextrins and 2,4-dichlorprop methyl ester enantiomers by UV spectra
by: LI Hong, et al.
Published: (2008-01-01)

Effect of Extinction on Separation of Nanoparticle Enantiomers With Chiral Optical Forces
by: Semen A. Andronaki, et al.
Published: (2017-01-01)

Cytochrome P450 Epoxygenase CYP2J2 G-50T Polymorphism is an Independent Genetic Prognostic Risk Factor and Interacts with Smoking Cessation After Index Premature Myocardial Infarction
by: Liu, Ping-Yen, et al.
Published: (2012)

Regional aspects of associations of the CYP2C19 gene polymorphism with coronary atherosclerosis in acute coronary syndrome
by: K. Yu. Nikolaev, et al.
Published: (2018-11-01)

Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Anti-Neoplastic Agents
by: Lexcen, Daniel, et al.
Published: (2012)

ω3 and ω6 CYP450 Eicosanoid Derivatives: Key Lipid Mediators in the Regulation of Pulmonary Hypertension
by: Morin, Caroline, et al.
Published: (2011)

Pharmacokinetic Study of Viral Vectors for Gene Therapy: Progress and Challenges
by: Xu, Xianxing, et al.
Published: (2011)

Pyrrole-Imidazole Polyamides for Gene Therapy: Bioanalytical Methods and Pharmacokinetics
by: Kamei, Tomonori, et al.
Published: (2011)

A physiologically‐based pharmacokinetic/pharmacodynamic modeling approach for drug–drug‐gene interaction evaluation of S‐warfarin with fluconazole
by: Kuo Geng, et al.
Published: (2024-05-01)

POLYMORPHISMS OF THE CYP1A1, CYP1A2, CYP19, AND SULT1A1 GENES ARE NOT ASSOCIATED WITH INFERTILITY IN WOMEN WITH GENITAL ENDOMETRIOSIS
by: LARISA N. Danilova, et al.
Published: (2018-09-01)

Pharmacogenomics Dictate Pharmacokinetics: Polymorphisms in Drug-Metabolizing Enzymes and Drug-Transporters
by: Mondal, Debasis, et al.
Published: (2012)

Evaluation of the Influence of <i>CYP2C9* 2, CYP2C9*3</i> Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery
by: T. E. Morozova, et al.
Published: (2021-09-01)

Chiral membrane with intrinsic microporosity for enantioselective electrochemical recognition of tryptophan enantiomers
by: Wanshuang Zhou, et al.
Published: (2025-01-01)

CYP2C19 Phenotype, P2Y12 Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy
by: Rajiv C. Patel, et al.
Published: (2025-07-01)

Application of Pharmacokinetics/Pharmacodynamics (PK/PD) in Designing Effective Antibiotic Treatment Regimens
by: Ahmed, Ghada F., et al.
Published: (2012)

Pharmacokinetic (PK) and Pharmacodynamic Profiles of Artemisinin Derivatives Influence Drug Neurotoxicity in Animals
by: Li, Qigui, et al.
Published: (2012)